Trading Options with an Edge
Select Page

MDGL

Search by
TICKER SYMBOL

Madrigal Pharmaceuticals Inc

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing

65.14

2.65

(4.241%)

Volume:

284,564

52 week range:

52.33 - 105.93

Market Cap:

1.114B

Company Description:

Madrigal Pharmaceuticals is a clinical-stage biopharmaceutical company pursuing novel therapeutics that target a specific thyroid hormone pathway in the liver, which is a key regulatory mechanism common to a spectrum of cardio-metabolic and fatty liver diseases with high unmet medical need. Madrigal recognizes that compounds with greater selectivity for thyroid hormone receptor (THR)-ß and liver uptake has the greatest potential to overcome challenges faced by prior, less selective compounds and deliver the full therapeutic potential of THR-ß agonism. The Company believes that resmetirom, its lead product candidate, is the first orally administered, small-molecule, liver-directed, truly ß-selective THR agonist.